Endonovo Therapeutics Inc (ENDV)

[Doyle McBoyle1]

I think the main focus should be generating revenue with sofpulse. I wanna see more distribution agreements and more sales, they’re very promising but endv needs to get some recognition and right now with the fda releasing that article about how they’re looking for devices to solve the opioid problem is a great time. They’re needs to be some type of movement here we can’t just keep sitting at .03 cents and every time we get a PR go up a little bit and come back down. We’ve all been pretty patient and I think that’s a little ridiculous to think I’m gonna wait 2 years for them to say we didn’t get the patents or the clinical trials weren’t that great. Sofpulse should be at the top of the list right now generating the most sales possible to get some type of return and use that cash to fund the future operations. That’s what’s gonna get us moving, not every couple weeks them releasing a new PR that says things are looking good cause that clearly hasn’t worked in the past and any momentum from those was lost in the matter of days. I’m long on endv and am willing to be patient, but i do think it’s a little silly for people to accept waiting that long when from a business perspective they could be profitable and we can be making money along the way while were waiting for these patents and trial results